Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sabinsa adds Canadian patent

This article was originally published in The Tan Sheet

Executive Summary

The Piscataway, N.J.-based dietary supplement manufacturer on Aug. 6 says it has added a patent from Canada to its U.S., European and Japanese patents protecting its Bioperine branded ingredient, which is derived from piperine black pepper extract, for use as a bioavailability enhancer. The firm says Bioperine is the only piperine that can legally be used in Canada to enhance the bioavailability of nutrients in supplement products. Sabinsa retained exclusive U.S. proprietary rights to its BioPerine and Forslean (coleus forkskohlii) ingredients in June with a final judgment by the U.S. District Court for the District of New Jersey against DNP International, which Sabinsa sued for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s (1"The Tan Sheet" July 9, 2007, In Brief)...

You may also be interested in...



Sabinsa secures process patent

Sabinsa Corp. secures a new herbal manufacturing process patent covering its proprietary method of easily accessing known polyphenols and a streamlined approach to discovering unknown polyphenolic compounds, the company announces Aug. 27. The Piscataway, N.J.-based firm won the '324 patent six months after submitting materials to USPTO related to the methods and processes used to manufacture stilbene-polyphenols which exhibit various health benefits including resveratrol, oxyresveratrol and pterostilbene. The patent also covers the firm's process for synthesizing biologically active polyphenolic compounds by novel dalkylation, an aromatic poly o-demethlyation process used in polyphenol manufacturing. The firm recently added Canadian protection to its list of U.S. and international patents protecting its Bioperine brand ingredient 1("The Tan Sheet" Aug. 13, 2007, In Brief)...

District court upholds herbal extract patents

Herbal extract firm Sabinsa Corp. retains exclusive proprietary rights to BioPerine (piperine black pepper extract) and Forslean (coleus forkskohlii), the U.S. District Court for the District of New Jersey says in a June 27 final judgment against DNP International. The ruling upholds the validity and enforceability of the '382, '596 and '712 patents pertaining to Sabinsa's products. DNP agreed to discontinue importing, manufacturing and/or marketing piperine, coleus and coleus oil for sale in the United States. Sabinsa sued DNP for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s, the company says. Piscataway, N.J.-based Sabinsa manufactures Phytonutrients and Ayurvedic herbal extracts for nutritional, pharmaceutical and food products...

Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question

Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug? 

Topics

UsernamePublicRestriction

Register

PS100805

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel